Genprex Inc Earnings

The next earnings date for Genprex Inc has not yet been scheduled.

Analyst Estimates of Genprex Inc Earnings

No Results.
Report DateEstimated Earnings Per Share
No Results.

What is an Earnings Date

An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.

Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.

Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.

Genprex Inc Earnings: Historical

Report DateBefore/After MarketEarnings Per ShareSurprise %
05/13/2025After Market$-0.2689.76%
03/31/2025After Market------
11/12/2024Before Market$-1.2336.27%
08/09/2024After Market$-3-30.43%
05/15/2024After Market$-3.69-45.28%
02/26/2024After Market$-3.96-0.76%
11/14/2023After Market$-0.13-18.18%
08/21/2023After Market$-0.15-25.00%
05/22/2023After Market$-0.19-58.33%
03/31/2023---$-0.1313.33%
11/14/2022Before Market$-0.13-8.33%
08/12/2022After Market$-0.118.33%
05/13/2022After Market$-0.120.00%
03/30/2022After Market$-0.12-33.33%
11/15/2021Before Market$-0.0736.36%
08/13/2021After Market$-0.0838.46%
05/17/2021Before Market$-0.14-16.67%
03/26/2021After Market$-0.1450.00%
11/12/2020After Market$-0.0766.67%
08/11/2020After Market$-0.127.69%
05/14/2020After Market$-0.20-150.00%
11/14/2019After Market$-0.1531.82%
08/13/2019After Market$-0.24-14.29%
05/15/2019After Market$-0.1430.00%
03/29/2019---$-8-5,614.29%
11/14/2018After Market$-0.15-15.38%
08/14/2018Before Market$-0.31-82.35%
05/15/2018After Market$-0.05---
10/10/2017---$-0.07---
07/21/2017---$-0.05---

More About Genprex Inc

Country
USA
Full Time Employees
13

Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. The company's technologies are designed to administer disease-fighting genes to provide new therapies for patient populations with cancer and diabetes. Its oncology program utilizes its systemic, non-viral Oncoprex Delivery System, which encapsulates the gene-expressing plasmids using lipid-based nanoparticles in a lipoplex form. The company's lead product candidate, Reqorsa Immunogene Therapy (quaratusugene ozeplasmid), is being evaluated in three clinical trials as a treatment for NSCLC and SCLC. Its three-lung cancer clinical programs have received a Fast Track Designation from the FDA for the treatment of that patient population, and SCLC program has received an FDA Orphan Drug Designation. The company's diabetes gene therapy comprises of a novel infusion process that uses an AAV vector to deliver Pdx1 and MafA genes directly to the pancreas. In models of Type 1 diabetes, its GPX-002 transforms alpha cells in the pancreas into functional beta-like cells, which produce insulin but distinct enough from beta cells to evade the body's immune system; and GPX-002 for Type 2 diabetes, where autoimmunity is not at play, is believed to rejuvenate and replenish exhausted beta cells. It has research agreement with The University of Michigan Rogel Cancer Center and Lung Cancer Study Collaboration with ALK Positive. Genprex, Inc. was incorporated in 2009 and is based in Austin, Texas.

Genprex Inc Earnings” Can Refer to the Genprex Inc Earnings Date

Some people say “Genprex Inc earnings” as a shortform way to refer to the earnings date.

For example, someone might say, “I plan to hold my Genprex Inc position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.

Owning Genprex Inc Stock on the Earnings Date

If you own Genprex Inc stock (GNPX) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.

A company’s earnings typically have a big impact on its stock price, which explains why the stock price for Genprex Inc might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.

There is often a big audience of investors involved with trading Genprex Inc shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.

These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.

Learning More Genprex Inc Earnings

You can contact us any time if you would like to ask questions about Genprex Inc earnings or anything else related to the stock market.